The following outbreaks, which occurred last year, illustrate the reality of zoonotic influenza, the fact that all ages can be vulnerable, that those with and without comorbidities can be at risk, and that various exposures can lead to swine-origin influenza A(H1N1) influenza infection.
Fatal Human Swine Flu in Brazil
On 7 June 2023, WHO was notified of a fatal laboratory-confirmed human case of infection with a swine-origin influenza A(H1N1) variant (v) virus in the inner state of Paraná. The patient was a 42-year-old woman with underlying medical conditions who lived near a swine farm. She developed fever, headache, sore throat, and abdominal pain on 1 May 2023 and was hospitalized on 3 May with a severe acute respiratory infection. On 4 May, the patient was admitted to the Intensive Care Unit and she passed away on 5 May. Ongoing investigations reported that the patient did not have any direct contact with pigs, however, two of her close contacts worked at a swine farm. The two contacts did not develop respiratory disease and tested negative for influenza. Sporadic human cases of influenza A(H1N1)v have been reported previously, including from Brazil.
Find out more about this outbreak here.
Adolescent Swine Flu – Michigan
On 4 August 2023, WHO was notified of a human infection with a novel influenza A(H1N2) variant virus identified in the State of Michigan. The case was under 18 years old, with no comorbidities and was not hospitalized. Investigation by local public health officials identified swine exposure by the patient at an agricultural fair that took place between 23 and 29 July, within 10 days prior to illness onset. This was the first influenza A(H1N2)v virus infection identified in the United States in 2023. Since 2005, there have been 512 influenza A variant virus infections (all subtypes), including 37 (human infections with influenza A (H1N2)v viruses reported in the United States.
Find out more about this outbreak here.
Unknown Source of Infection – The Netherlands
On 2 September 2023, WHO was notified of a laboratory-confirmed human case of infection with a swine-origin influenza A(H1N1) variant (v) virus in the province of North Brabant, Netherlands. The case was an adult with no underlying medical conditions and no history of occupational exposure to animals. As of 13 September, the person had recovered. This was the first human infection caused by influenza A(H1N1)v virus reported in the Netherlands in 2023. This case was picked up as part of routine surveillance of respiratory illnesses. Based on the available information, there was no clear indication of the source of infection, and no direct contact with pigs was reported.
Find out more about this outbreak here.
United Kingdom
On 25 November 2023, WHO was notified of a human case of swine-origin influenza A(H1N2) virus infection. The case reported onset of mild symptoms on 5 November. He visited his general practitioner on 9 November and as of 1 December was fully recovered. This case was identified after a respiratory sample was collected and further analyzed as part of routine surveillance of respiratory illnesses. According to ongoing investigations, pig farms were located within a few miles of where the case resided; however, the case reported no direct exposure to pigs, pets, or farms. The source of infection was under investigation and contact tracing was continuing. This influenza A(H1N2)v virus belonged to the swine influenza virus genetic clade 1B.1.1. Similar A(H1N2) viruses from this genetic clade have been previously detected in pigs in the United Kingdom. However, this is the first time a virus from this swine genetic clade has been detected in a human in the United Kingdom.
Find out more about this outbreak here.
Source: World Health Organization, adapted
RELATED READING
Investigation of the the infection dynamics of 2 influenza A(H1N1) virus isolates from the swine. Both H1N1 viruses could infect pigs and were transmitted to cohoused ferrets. Ferrets vaccinated with a human 2016–17 seasonal influenza vaccine were protected against infection with the antigenically matched 1A pandemic 2009 virus but not against the swine-lineage 1C virus. Results reaffirm the need for continuous influenza A virus surveillance in pigs and identification of candidate human vaccine viruses. (Emerging Infectious Diseases)
Unravelling Influenza Correlates of Protection: Lessons from Human A/H1N1 Challenge
The gold standard for understanding the true protective efficacy of influenza vaccines lies in human challenge studies as large-scale efficacy trials are costly and difficult to implement. Challenging vaccinated individuals allows researchers to observe not only symptomatic outcomes but also the dynamics of viral shedding and correlate these to pre-challenge (baseline) immune responses. The Bean et al. study with an updated A/H1N1 human challenge virus has provided a unique opportunity to investigate protective immunity, shedding light on the real-world COP which will aid in the development of improved influenza vaccines. (mBio)
Long-Term Epidemiology and Evolution of Swine Influenza Viruses, Vietnam
Influenza A viruses are a One Health threat because they can spill over between host populations, including among humans, swine, and birds. Surveillance of swine influenza virus in Hanoi, Vietnam, during 2013–2019 revealed gene pool enrichment from imported swine from Asia and North America and showed long-term maintenance, persistence, and reassortment of virus lineages. (Emerging Infectious Diseases)